Cathie Wood’s 5 Stock Picks for the Next 5 Years

4. CRISPR Therapeutics AG (NASDAQ:CRSP)

Number of Hedge Fund Holders: 34

CRISPR Therapeutics AG (NASDAQ:CRSP) is a gene-editing firm. CRISPR Therapeutics AG (NASDAQ:CRSP) has featured in the ARK portfolio, with minor interruptions, since the second quarter of 2017. The fund owned over 9 million shares in the company at the end of December 2021 worth $688 million. 

Institutional investors hold large stakes in CRISPR Therapeutics AG (NASDAQ: CRSP). At the end of the fourth quarter of 2021, 34 hedge funds in the database of Insider Monkey held stakes worth $994 million in CRISPR Therapeutics AG (NASDAQ:CRSP), compared to 43 in the preceding quarter worth $1.2 billion.